Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1681268Generated: November 3, 2026

Aminoglutethimide → Trehalose

https://huagongshe.com/reaction/1681268

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAminoglutethimideHCID 2145—
ReactantSucroseHCID 5988—
ReactantSulfuric acid magnesium salt (1:1)HCID 24083—
ReactantSodium NitrateHCID 24268—
Reactant(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanalHCID 107526—
ReactantMonobasic potassium phosphateHCID 516951—
Reactant(2S,3S,4R,5R,6S)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1R,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triolHCID 44568492—
CatalystFerrous SulfateHCID 24393—
SolventWaterHCID 962—
ProductTrehaloseHCID 7427—

Reaction Steps

100 ml of a modified Czapek's liquid culture medium (consisting of glucose 30 g, magnesium sulfate 0.5 g, sodium nitrate 2 g, potassium dihydrogenphosphate 1 g, iron sulfate 0.01 g and deionized water 1000 ml) was put into a 200 ml.-capacity flask, which was sterilized at 115°C. for 15 minutes. The resultant culture medium was inoculated with a pieceof the growth (punched out with a cork borer, diameter 1 cm) of Rhizoctoniasolani AG-1 (accession number IFO-30465) cultured on a potato sucrose agar (PSA) culture medium at 28° C. for two days, which was subjected toshake-culture at 28° C. for four days. Then the same experiment was carried out with the exception that validamycin A was added to the culturemedium before the cultivating the medium, the amount of validamycin A being0.005% relative to the whole culture medium. In each of the two experiments, the culture cells obtained thus above were respectively separated and purified, followed by subjecting to quantitative determination. As shown in Table 1, from the culture cells by culturing inthe medium to which validamycin A was supplemented, a remarkably increased amount of trehalose was obtained as compared with those by culturing in the medium to which no validamycin A was supplemented.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05169767
Source datasetuspto-grants-1992_12
ORD IDord-4cf6f2770e484add8e7a4ecb98eba1cd
Source noteuspto-grants-1992_12